Status:
COMPLETED
Glulisine Pre- and Postmeal
Lead Sponsor:
Sanofi
Conditions:
Diabetes Mellitus Type 1
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
Brief Summary
To investigate in type 1 diabetic patients the glucodynamic response to HMR1964 insulin and RHI (HOE31HPR100) injected subcutaneously before and after a standard meal
Eligibility Criteria
Inclusion
- Type 1 diabetes mellitus
Exclusion
Key Trial Info
Start Date :
December 1 2001
Trial Type :
INTERVENTIONAL
End Date :
March 1 2002
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00290043
Start Date
December 1 2001
End Date
March 1 2002
Last Update
December 6 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.